ProCE Banner Activity

ExpressPoints: The New Biomarkers Pathologists Need to Know for Precision Therapy in Lung Cancer

Slideset Download
Download this short summary slideset of key takeaways from a live CCO Webinar featuring a medical oncologist and molecular pathologist discussing established and emerging biomarkers critical to optimal treatment of patients with advanced NSCLC.

Released: November 24, 2020

Share

Faculty

Nathan Pennell

Nathan Pennell, MD, PhD

Professor
Director,
Cleveland Clinic Lung Cancer Medical Oncology Program
Department of Hematology and Medical Oncology
Cleveland Clinic Taussig Cancer Institute
Cleveland, Ohio

Laura J. Tafe

Laura J. Tafe, MD

Associate Professor of Pathology and Laboratory Medicine
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire
The Geisel School of Medicine at Dartmouth
Hanover, New Hampshire

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Faculty Disclosure

Primary Author

Nathan Pennell, MD, PhD

Professor
Director,
Cleveland Clinic Lung Cancer Medical Oncology Program
Department of Hematology and Medical Oncology
Cleveland Clinic Taussig Cancer Institute
Cleveland, Ohio

Laura J. Tafe, MD

Associate Professor of Pathology and Laboratory Medicine
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire
The Geisel School of Medicine at Dartmouth
Hanover, New Hampshire